Treatment of vascular calcification
A technology of vascular calcification and solvate, which is used in the field of compounds for the treatment of medial vascular calcification or intimal atherosclerotic calcification, and can solve problems such as adverse effects on mechanical properties of vascular tissue and matrix hardening.
A technology of vascular calcification and solvate, which is used in the field of compounds for the treatment of medial vascular calcification or intimal atherosclerotic calcification, and can solve problems such as adverse effects on mechanical properties of vascular tissue and matrix hardening.
CN109475533AActive Publication Date: 2019-03-15CAMBRIDGE ENTERPRISE LTD +1
Image
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0133] Example 1: Demonstration of the physiological link between poly(ADP ribose) (PAR) and vascular calcification;
Embodiment 2
[0134] Embodiment 2: detecting the toxicity of PARP inhibitor / tetracycline to bovine vascular smooth muscle cells;
Embodiment 3
[0135] Embodiment 3: Detect the toxicity of PARP inhibitor / tetracycline to human monocyte macrophage;
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to the use of a poly(ADP ribose) polymerase (PARP) inhibitor and / or a tetracycline, for treating, preventing or ameliorating medial vascular calcification or intimal atherosclerotic calcification, and to pharmaceutical compositions comprising PARP inhibitors or tetracycline.
Description
technical field [0001] The present invention relates to vascular calcification, and in particular to compounds useful in the treatment of diseases associated with excessive and / or inappropriate vascular calcification. In particular, the invention relates to the treatment of medial vascular calcification or intimal atherosclerotic calcification. The present invention relates to pharmaceutical compositions and methods for the treatment of excessive and / or inappropriate (ie, medial) vascular calcification. Background technique [0002] Vascular calcification is associated with a range of diseases and can be broadly classified into three distinct types, namely (1) intimal atherosclerotic calcification, which is intimal calcification and includes atherosclerosis and associated inflammation; (2) valvular calcification aortic stenosis, which is calcification of the aortic valve; and (3) medial calcification, which is calcification of the media, see Demer and Tintut "Vascular Calci...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
15 Mar 2019
Publication
CN109475533A
- IPC
- A61K31/4184; A61K31/454; A61K31/4709; A61K31/502; A61K31/5025; A61K31/55; A61K31/65; A61K45/06; A61P9/10; A61P9/14
- CPC
- A61K45/06; A61K31/4184; A61K31/454; A61K31/502; A61K31/5025; A61K31/55; A61K31/47; A61K31/50
- Inventors
- M·杜尔; D·里德